Tuesday, September 15, 2026

FDA Adjusts Drug Review Fees: Higher for New Drugs, Lower for Generics

The FDA’s 2027 fee changes lower review costs for new drugs and biosimilars while raising fees for generics and medical devices, with the impact varying by company.

2026 Milan-Cortina Olympics: Trump’s “Loser” Jab at an Athlete Ignites a Team USA Reckoning

Chloe Kim calls for empathy amid debates on social divisions at the 2026 Winter Olympics, following Trump's criticism of Hunter Hess.

AI Showdown: China’s Strategic Move to Outmaneuver U.S. Tech

© News1 Amid an intensifying push for...

Tag: development

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Korea University Launches Next-Generation Hantavirus Vaccine Project Under National Pandemic Preparedness Program

Korea University is developing a next-gen hantavirus vaccine through public-private collaboration, aiming for rapid production during pandemics.

POSTECH Develops Single-Device Transistor Capable of Performing Multiple Circuit Functions

POSTECH researchers led by Professor Lee Byung-hoon developed a next-gen transistor enabling multiple functions in one semiconductor device.

AriBio Advances Global Alzheimer’s Strategy With Multibillion-Dollar AR1001 Licensing Deal

AriBio secures a $4.67 billion licensing deal for Alzheimer's drug AR1001 with Puxing Pharmaceutical, aiming for global commercialization.

CHA Biotech Partners With Thermo Fisher to Build K-Bio Open Innovation Hub in Pangyo

Cha Biotech partners with Thermo Fisher to establish K-Bio CIC, enhancing biotech innovation and global market entry support.

Onyou Tech Unveils AI Lighting Control System Aimed at Cutting Power Use Without Fixture Replacement

Onyou Tech's AI Power Saver can cut electricity use by 50%, saving 5.7 GW annually, urging quick adoption by government and institutions.

KAIST Study on Plant-Interactive Gameplay Wins Best Paper Award at CHI 2026

Researchers at KAIST propose a new interaction model where plants engage in digital gameplay, fostering emotional connections with users.

HLB Group Maps Commercialization Push as It Awaits Key U.S. Cancer Drug Decisions

HLB Group seeks FDA approval for cancer drugs, aiming for global impact through innovation and collaboration in the biotech sector.

KDDF Chief Calls for Structural Shift in Korea Biotech Beyond Technology Transfer

Dr. Park Young-min urges South Korea's biotech sector to shift from tech transfer to global collaboration for sustainable growth.

A Long-Acting Oral Drug? Yuhan’s Latest Trial Update Is Turning Heads

Yuhan Corp's YH35995 shows promising results for Gaucher disease in Phase 1 trial, demonstrating long-lasting efficacy and BBB penetration.

A Record Year in China Is Giving Hanmi Pharmaceutical More Firepower for What’s Next

Hanmi Pharmaceutical's Chinese subsidiary surpassed $290M in sales, contributing significantly to the group's growth and future investments.

Matica BIOLABS Signs CMO with Jeongjin Bioscience for Mesenchymal Stem Cell Culture Media Production

Matica BIOLABS partners with Jeongjin Bioscience for stem cell media production and expands operations with Humic for drug development.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

Qurient Mocaciclib’s CDK7 Inhibitor is Revolutionizing High-Risk Pediatric Brain Cancer Therapy

Qurient's Mocaciclib shows promising results for pediatric brain tumors, enhancing survival and overcoming treatment barriers.

Hyundai Engineering Secures $309 Million for U.S. Solar Power Plant Project in Texas

Hyundai Engineering secures $309M for Texas solar project, aiming for 200MW capacity and commercial operations by 2027.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.